Compared with other clinicopathological features, the TERT promoter mutations possibly make more contribution to distant metastasis and advanced TNM stage of DTC, especially to distant metastasis of FTC (OR = 24.29). This evidence concerns the gene TERT and thyroid cancer, nonmedullary, 2.